{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T21:11:07Z","timestamp":1776114667945,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673364"],"award-info":[{"award-number":["81673364"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["2632018PY10"],"award-info":[{"award-number":["2632018PY10"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"crossref","award":["2632018YX02"],"award-info":[{"award-number":["2632018YX02"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ejps.2018.04.022","type":"journal-article","created":{"date-parts":[[2018,4,18]],"date-time":"2018-04-18T02:47:31Z","timestamp":1524019651000},"page":"189-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Cisplatin-stitched \u03b1-poly(glutamatic acid) nanoconjugate for enhanced safety and effective tumor inhibition"],"prefix":"10.1016","volume":"119","author":[{"given":"Huimin","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yerong","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruijuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yinglan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiamin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengxia","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6588-6047","authenticated-orcid":false,"given":"Chunmeng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiasheng","family":"Tu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8503-9099","authenticated-orcid":false,"given":"Dongsheng","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2018.04.022_bb0005","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1742-7843.2006.00024.x","article-title":"Carnitine deficiency provokes cisplatin-induced hepatotoxicity in rats","volume":"100","author":"Al-Majed","year":"2007","journal-title":"Basic Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2018.04.022_bb0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1139\/cjpp-2015-0304","article-title":"Ameliorative effect of trimetazidine on cisplatin-induced hepatotoxicity in rats","volume":"94","author":"Ateyya","year":"2016","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.ejps.2018.04.022_bb0015","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1021\/ja01586a020","article-title":"Polypeptides. III. The synthesis of high molecular weight poly-\u03b3-benzyl-l-glutamates","volume":"78","author":"Blout","year":"1956","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejps.2018.04.022_bb0020","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1124\/dmd.30.12.1378","article-title":"Kinetic study of the reaction of cisplatin with thiols","volume":"30","author":"Dabrowiak","year":"2002","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2018.04.022_bb0025","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejps.2018.04.022_bb0030","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1021\/acs.biomac.6b01411","article-title":"Cisplatin-stitched polysaccharide vesicles for synergistic cancer therapy of triple antagonistic drugs","volume":"18","author":"Deshpande","year":"2017","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejps.2018.04.022_bb0035","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cbi.2007.07.014","article-title":"Dimethylthiourea protects against mitochondrial oxidative damage induced by cisplatin in liver of rats","volume":"170","author":"dos Santos","year":"2007","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejps.2018.04.022_bb0040","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.addr.2012.08.012","article-title":"Polymer therapeutics-prospects for 21st century: the end of the beginning","volume":"65","author":"Duncan","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2018.04.022_bb0045","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.ijpharm.2015.10.066","article-title":"pH sensitive polymeric complex of cisplatin with hyaluronic acid exhibits tumor-targeted delivery and improved in vivo antitumor effect","volume":"496","author":"Fan","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.04.022_bb0050","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.3390\/cancers3011351","article-title":"Cisplatin as an anti-tumor drug: cellular mechanisms of activity, drug resistance and induced side effects","volume":"3","author":"Florea","year":"2011","journal-title":"Cancers"},{"key":"10.1016\/j.ejps.2018.04.022_bb0055","first-page":"219","article-title":"Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man","volume":"50","author":"Freireich","year":"1966","journal-title":"Cancer Chemother. Rep."},{"key":"10.1016\/j.ejps.2018.04.022_bb0060","first-page":"1233","article-title":"Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update","volume":"86","author":"Guinaim dos Santos","year":"2012","journal-title":"Basic Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2018.04.022_bb0065","first-page":"513","article-title":"Intracellular GSH alterations and its relationship to level of resistance following exposure to cisplatin in cancer cells","volume":"14","author":"Jamalia","year":"2015","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.ejps.2018.04.022_bb0070","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1021\/cr980421n","article-title":"Structure, recognition, and processing of cisplatin-DNA adducts","volume":"99","author":"Jamieson","year":"1999","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejps.2018.04.022_bb0075","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.kint.2015.11.021","article-title":"Autophagy in acute kidney injury","volume":"89","author":"Kaushal","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejps.2018.04.022_bb0080","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1039\/C4PY01592D","article-title":"Tumor-targeting delivery of hyaluronic acid-platinum(IV) nanoconjugate to reduce toxicity and improve survival","volume":"6","author":"Ling","year":"2015","journal-title":"Polym. Chem."},{"key":"10.1016\/j.ejps.2018.04.022_bb0085","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1002\/adhm.201400108","article-title":"Synergistic antitumor effects of doxorubicin-loaded carboxymethyl cellulose nanoparticle in combination with endostar for effective treatment of non-small-cell lung cancer","volume":"3","author":"Li","year":"2014","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.ejps.2018.04.022_bb0090","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.actbio.2015.02.022","article-title":"Targeted delivery of cisplatin by LHRH-peptide conjugated dextran nanoparticles suppresses breast cancer growth and metastasis","volume":"18","author":"Li","year":"2015","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejps.2018.04.022_bb0095","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.biomaterials.2012.10.073","article-title":"PEG-derivatized embelin as a nanomicellar carrier for delivery of paclitaxel to breast and prostate cancers","volume":"34","author":"Lu","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2018.04.022_bb0100","doi-asserted-by":"crossref","first-page":"6742","DOI":"10.1002\/anie.201201562","article-title":"Combating the drug resistance of cisplatin using a platinum prodrug based delivery system","volume":"51","author":"Min","year":"2012","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejps.2018.04.022_bb0105","doi-asserted-by":"crossref","first-page":"627","DOI":"10.4155\/tde.14.36","article-title":"Research spotlight: emergence of EPR effect theory and development of clinical applications for cancer therapy","volume":"5","author":"Maeda","year":"2014","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ejps.2018.04.022_bb0110","doi-asserted-by":"crossref","first-page":"76987","DOI":"10.1039\/C5RA15740D","article-title":"In vitro model reaction of sulfur containing bio-relevant ligands with Pt(II) complex: kinetics, mechanism, bioactivity and computational studies","volume":"5","author":"Mukherjee","year":"2015","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejps.2018.04.022_bb0115","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1517\/17425247.2014.955011","article-title":"Development of next-generation macromolecular drugs based on the EPR effect: challenges and pitfalls","volume":"12","author":"Nakamura","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2018.04.022_bb0120","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.addr.2013.09.014","article-title":"Nanocarriers for delivery of platinum anticancer drugs","volume":"65","author":"Oberoi","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2018.04.022_bb0125","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.ki.5002786","article-title":"Cisplatin nephrotoxicity: mechanisms and renoprotective strategies","volume":"73","author":"Pabla","year":"2008","journal-title":"Kidney Int."},{"key":"10.1016\/j.ejps.2018.04.022_bb0130","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/polc.5070510111","article-title":"Structure and properties of pharmacologically active polymers","volume":"51","author":"Ringsdorf","year":"1975","journal-title":"J. Polym. Sci. Polym. Symp."},{"key":"10.1016\/j.ejps.2018.04.022_bb0135","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/222385a0","article-title":"Platinum compounds: a new class of potent antitumour agents","volume":"222","author":"Rosenberg","year":"1969","journal-title":"Nature"},{"key":"10.1016\/j.ejps.2018.04.022_bb0140","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0168-3659(89)90019-9","article-title":"Soluble polymers as carriers of cis-platinum","volume":"10","author":"Schechter","year":"1989","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.ejps.2018.04.022_bb0145","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jconrel.2016.02.039","article-title":"Combining disulfiram and poly(l-glutamic acid)-cisplatin conjugates for combating cisplatin resistance","volume":"231","author":"Song","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2018.04.022_bb0150","first-page":"17964","article-title":"Core-shell polymer nanoparticles for prevention of GSH drug detoxification and cisplatin delivery to breast cancer cells","volume":"7","author":"Surnar","year":"2015","journal-title":"Nano"},{"key":"10.1016\/j.ejps.2018.04.022_bb0155","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1023\/A:1014268729658","article-title":"HPLC determination of binding of cisplatin to DNA in the presence of biological thiols: implications of dominant platinum-thiol binding to its anticancer action","volume":"19","author":"Volckova","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2018.04.022_bb0160","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2174\/187152007779314062","article-title":"The role of sulfur in platinum anticancer chemotherapy","volume":"7","author":"Wang","year":"2007","journal-title":"Anti-Cancer Agent. ME"},{"key":"10.1016\/j.ejps.2018.04.022_bb0165","doi-asserted-by":"crossref","first-page":"4297","DOI":"10.1016\/j.biomaterials.2014.01.035","article-title":"Cisplatin-alginate conjugate liposomes for targeted delivery to EGFR-positive ovarian cancer cells","volume":"35","author":"Wang","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2018.04.022_bb0170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijpharm.2015.02.027","article-title":"A polymeric prodrug of cisplatin based on pullulan for the targeted therapy against hepatocellular carcinoma","volume":"483","author":"Wang","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2018.04.022_bb0175","doi-asserted-by":"crossref","first-page":"7732","DOI":"10.1016\/j.biomaterials.2011.06.072","article-title":"Biodegradable polymer - cisplatin(IV) conjugate as a pro-drug of cisplatin(II)","volume":"32","author":"Xiao","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2018.04.022_bb0180","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jconrel.2012.06.004","article-title":"Co-delivery of daunomycin and oxaliplatin by biodegradable polymers for safer and more efficacious combination therapy","volume":"163","author":"Xiao","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2018.04.022_bb0185","doi-asserted-by":"crossref","first-page":"6507","DOI":"10.1016\/j.biomaterials.2012.05.049","article-title":"A prodrug strategy to deliver cisplatin(IV) and paclitaxel in nanomicelles to improve efficacy and tolerance","volume":"33","author":"Xiao","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2018.04.022_bb0190","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.jconrel.2013.10.020","article-title":"Photosensitive Pt(IV)-azide prodrug-loaded nanoparticles exhibit controlled drug release and enhanced efficacy in vivo","volume":"173","author":"Xiao","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2018.04.022_bb0195","doi-asserted-by":"crossref","first-page":"7182","DOI":"10.1016\/j.biomaterials.2012.06.071","article-title":"A poly(gamma, l-glutamic acid)-citric acid based nanoconjugate for cisplatin delivery","volume":"33","author":"Xiong","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejps.2018.04.022_bb0200","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jconrel.2014.12.022","article-title":"Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(l-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy","volume":"205","author":"Yu","year":"2015","journal-title":"J. Control. Release"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718301878?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098718301878?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,19]],"date-time":"2020-05-19T09:00:00Z","timestamp":1589878800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098718301878"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":40,"alternative-id":["S0928098718301878"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2018.04.022","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cisplatin-stitched \u03b1-poly(glutamatic acid) nanoconjugate for enhanced safety and effective tumor inhibition","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2018.04.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}